| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2014PLoSO...995760M |
| P356 | DOI | 10.1371/JOURNAL.PONE.0095760 |
| P932 | PMC publication ID | 3994142 |
| P698 | PubMed publication ID | 24752617 |
| P5875 | ResearchGate publication ID | 261771629 |
| P2093 | author name string | Hitomi Kanno | |
| Kazushige Mizoguchi | |||
| Yasushi Ikarashi | |||
| Yoshio Kase | |||
| P2860 | cites work | The blood-brain barrier permeability of 18β-glycyrrhetinic acid, a major metabolite of glycyrrhizin in Glycyrrhiza root, a constituent of the traditional Japanese medicine yokukansan | Q47211312 |
| Isoliquiritigenin is a novel NMDA receptor antagonist in kampo medicine yokukansan | Q47288597 | ||
| Yokukansan, a traditional Japanese medicine, ameliorates memory disturbance and abnormal social interaction with anti-aggregation effect of cerebral amyloid β proteins in amyloid precursor protein transgenic mice | Q47322870 | ||
| Ameliorative effect of traditional Japanese medicine yokukansan on age-related impairments of working memory and reversal learning in rats | Q47331446 | ||
| Age-related changes of astorocytes, oligodendrocytes and microglia in the mouse hippocampal CA1 sector | Q48247897 | ||
| Astrocyte-derived ATP modulates depressive-like behaviors | Q48478374 | ||
| Glutamate transporter protein subtypes are expressed differentially during rat CNS development. | Q48617168 | ||
| Geissoschizine methyl ether, an alkaloid in Uncaria hook, is a potent serotonin ₁A receptor agonist and candidate for amelioration of aggressiveness and sociality by yokukansan | Q48669381 | ||
| Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain | Q49142951 | ||
| Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat. | Q52062439 | ||
| Glycyrrhetinic acid bound to 11 beta-hydroxysteroid dehydrogenase in rat liver microsomes | Q67589088 | ||
| Specific binding of glycyrrhetinic acid to the rat liver membrane | Q70220127 | ||
| Bioavailability study of glycyrrhetic acid after oral administration of glycyrrhizin in rats; relevance to the intestinal bacterial hydrolysis | Q71763838 | ||
| The synthesis of 18beta-glycyrrhetinic acid derivatives which have increased antiproliferative and apoptotic effects in leukemia cells | Q80473192 | ||
| Amyloid β-induced death in neurons involves glial and neuronal hemichannels | Q83750709 | ||
| Probenecid, a gout remedy, inhibits pannexin 1 channels | Q24647558 | ||
| Genome-wide atlas of gene expression in the adult mouse brain | Q26253934 | ||
| Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease | Q27334874 | ||
| Localization of neuronal and glial glutamate transporters | Q28238076 | ||
| 11beta-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action? | Q28301624 | ||
| Transient ischemia stimulates glial fibrillary acid protein and vimentin gene expression in the gerbil neocortex, striatum and hippocampus | Q28343188 | ||
| Synchronized oscillations at alpha and theta frequencies in the lateral geniculate nucleus | Q33201809 | ||
| Specific glial functions contribute to schizophrenia susceptibility | Q33762530 | ||
| Review of pharmacological effects of Glycyrrhiza sp. and its bioactive compounds | Q34011396 | ||
| GFAP in health and disease. | Q34158294 | ||
| A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. | Q34554967 | ||
| Yokukansan in the treatment of behavioral and psychological symptoms of dementia: a systematic review and meta-analysis of randomized controlled trials | Q34566324 | ||
| Phenotypic and gene expression modification with normal brain aging in GFAP-positive astrocytes and neural stem cells | Q34981292 | ||
| NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease | Q35022998 | ||
| Emerging complexities in identity and function of glial connexins | Q36088580 | ||
| The gap junction proteome and its relationship to disease | Q37640469 | ||
| Binding of Glycyrrhetinic Acid to Kidney Mineralocorticoid and Glucocorticoid Receptors1 | Q39936780 | ||
| Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease. | Q42352469 | ||
| Treatment of behavioral and psychological symptoms of Alzheimer-type dementia with Yokukansan in clinical practice | Q43149382 | ||
| Glycyrrhizin and its metabolite 18 beta-glycyrrhetinic acid in glycyrrhiza, a constituent herb of yokukansan, ameliorate thiamine deficiency-induced dysfunction of glutamate transport in cultured rat cortical astrocytes | Q43264337 | ||
| Effects of yokukansan, a traditional Japanese medicine, on memory disturbance and behavioral and psychological symptoms of dementia in thiamine-deficient rats | Q43267459 | ||
| Inhibition of gap junction hemichannels by chloride channel blockers | Q43916372 | ||
| Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid | Q44325495 | ||
| Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease | Q44453943 | ||
| Blockade of glutamate release from microglia attenuates experimental autoimmune encephalomyelitis in mice | Q46124391 | ||
| Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease. | Q46166311 | ||
| Blockade of microglial glutamate release protects against ischemic brain injury | Q46385482 | ||
| Suppressive effect of Yokukansan on excessive release of glutamate and aspartate in the hippocampus of zinc-deficient rats | Q46568961 | ||
| Beta-amyloid and oxidative stress jointly induce neuronal death, amyloid deposits, gliosis, and memory impairment in the rat brain | Q46752254 | ||
| Functional contribution of specific brain areas to absence seizures: role of thalamic gap-junctional coupling | Q46899519 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e95760 | |
| P577 | publication date | 2014-04-21 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Specific binding and characteristics of 18β-glycyrrhetinic acid in rat brain | |
| P478 | volume | 9 |
| Q38325839 | Autoradiography techniques and quantification of drug distribution |
| Q42363344 | Cellular Pharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan on Brain Cells |
| Q57458436 | Central intracrine DHEA synthesis in ageing-related neuroinflammation and neurodegeneration: therapeutic potential? |
| Q47838951 | Effects of Glycyrrhetinic Acid on GSH Synthesis Induced by Realgar in the Mouse Hippocampus: Involvement of System [Formula: see text], System [Formula: see text], MRP-1, and Nrf2. |
| Q42367703 | Influences of yokukansankachimpihange on aggressive behavior of zinc-deficient mice and actions of the ingredients on excessive neural exocytosis in the hippocampus of zinc-deficient rats |
| Q39220519 | Multiple Psychopharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan, and the Brain Regions it Affects |
| Q26745471 | Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients |
Search more.